Transforming Ideas into Research Reality

Participants come to the ASH Clinical Research Training Institute with ideas and enthusiasm, and leave with new skills to conduct patient-oriented research. Just 20 years ago, it seemed as though the academic hematologist was at...

Online Exclusives

$3.5 Trillion Proposal by Senate Democrats Includes Drug Pricing Provisions to...

A $3.5 trillion draft package framework recently proposed by Senate Democrats includes several drug pricing provisions intended to help offset the costs of initiatives...

FDA Committee Votes Against Approval of Roxadustat for Anemia of Chronic...

The U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has decided not to recommend the approval of roxadustat for...

News

From the Blood Journals

Pain, Comorbidities Increase Risk of Severe COVID-19 in Patients with SCD

Research published in Blood Advances found patients with sickle cell disease (SCD) and a history of pain and renal and heart/lung comorbidities have a...
WIB_icon

Omidubicel Improves Outcomes, Reduces Hospital Stay for Patients with Hematologic Malignancies

Patients with hematologic malignancies who received umbilical cord blood transplantation with omidubicel engrafted faster, had fewer infections, and spent less time in the hospital, compared...

Multimedia

Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...

Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...

Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...

Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.

Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...

Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.

On Location

On location

Deep and Durable Responses Seen With CAR T-Cell Therapy for Pretreated Myeloma

In preliminary efficacy results, treatment with a single low-dose infusion of ciltacabtagene autoleucel (cilta-cel) led...
On location

Direct Oral Anticoagulants Versus LMWH in Preventing Recurrent VTE in Cancer

At the 2021 ASCO Annual Meeting, two posters reported results from the CANVAS trial, which...
On location

Functional, Nutritional, and Social Status Predict Survival Outcomes in Older Patients With CLL

Geriatric domains of functional status, social activity, and nutritional status were associated with overall survival...
On location

First-in-Human Study Finds FF-10101-01 Has Clinical Activity in Relapsed/Refractory FLT3-Mutated AML

For patients with relapsed and/or refractory FLT3-mutated acute myeloid leukemia (AML), treatment with the selective...
On location

R-CHOP Versus R-EPOCH: No Difference in Survival for Patients With MYC-Rearranged, Double- or Triple-Hit DLBCL

Overall survival (OS) outcomes were similar between patients with MYC-rearranged diffuse large B-cell lymphoma (DLBCL)...
On location

Investigators Identify Distinct Molecular Subgroups to Guide Treatment Decisions in AML

Analyzing genetic data from more than 3,000 patients with acute myeloid leukemia (AML), researchers from...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Responds to Investigation on SCT in Policy Custody Deaths, ASH Hematology Review Series...

ASH Responds to Investigation on Sickle Cell Trait Being Cited in Policy Custody Deaths The American Society of Hematology (ASH) has issued a position...
ASH Directions

ASH Minority Recruitment Initiative Seeks Mentors, ASH Joins in Support of the Federal Safe...

Mentors Needed for ASH Minority Recruitment Initiative The American Society of Hematology (ASH) Minority Recruitment Initiative (MRI), which was created nearly two decades ago to...

Sign up for our
eNewsletter!

The Society Pages

SAACR Awards Indian Americans for Cancer Research Discoveries, GBT Awards $450k to SCD Care...

Catherine Bollard Recognized for Mentorship and Cell-Based Therapy Research Catherine Bollard, MD, MBChB, director of the Center for Cancer and Immunology Research at Children’s National...
The Society Pages

Remembering Thomas Brock, Xavier Becerra Confirmed as U.S. Health Secretary, and more

Remembering Thomas Brock (1926 - 2021) Thomas Brock, PhD, died on April 4, 2021 at the age of 94. Dr. Brock’s discovery of a species...
The Society Pages

Senate Confirms Surgeon General and Assistant Secretary for Health, HVO Presents Golden Apple Awards,...

Brian Bolwell Named Chair of Physician Leadership and Development at Cleveland Clinic The Cleveland Clinic has appointed Brian Bolwell, MD, FACP, as chair of physician...

Transforming Ideas into Research Reality

Participants come to the ASH Clinical Research Training Institute with ideas and enthusiasm, and leave with new skills to conduct patient-oriented research. Just 20 years...

Breaking Down Barriers, Building Up Trust

Clinical trial enrollment has lacked diversity since the start, but a global racial reckoning has brought new attention to overcoming discrimination. According to the most...

Pain Pointers

Early intervention and careful management are critical in the treatment of peripheral neuropathy Peripheral neuropathy is a common occurrence in patients with hematologic diseases, whether...